The best treatment for diffuse large B-cell lymphoma: a German perspective.

Oncology (Williston Park, N.Y.)

Volumn 19, Issue 4 Suppl 1, 2005, Pages 16-25

  Schmits, Rudolf ^a   Schmitz, Norbert ^a   Pfreundschuh, Michael ^a  

^a German High Grade Non Hodgkin's Lymphoma Study Group (DSHNHL)   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

B CELL LYMPHOMA; DISEASE COURSE; DISEASE FREE SURVIVAL; GERMANY; HUMAN; LARGE CELL LYMPHOMA; PATHOLOGY; PROGNOSIS; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOXORUBICIN; GERMANY; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; PREDNISONE; PROGNOSIS; VINCRISTINE;

EID: 23444432521     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)